Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection

Helena Aegerter1, Justina Kulikauskaite1, Stefania Crotta1

  • 1Immunoregulation Laboratory, Francis Crick Institute, London, UK.

Nature Immunology
|January 15, 2020
PubMed

Insights

Influenza infection enhances lung antibacterial immunity for a month by recruiting new alveolar macrophages (AMs). These monocyte-derived AMs produce interleukin-6, offering protection that wanes over time.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Microbiology

Background:

  • Influenza's long-term impact on lung immunity remains poorly understood.
  • Understanding post-infection immune dynamics is crucial for managing secondary bacterial infections.

Purpose of the Study:

  • To investigate the long-term effects of influenza infection on lung immunity and host defense.
  • To characterize the immune cells responsible for altered protection after influenza recovery.

Main Methods:

  • Murine model of influenza infection followed by Streptococcus pneumoniae challenge.
  • Flow cytometry and transcriptomic analysis to phenotype and functionally assess alveolar macrophages (AMs).
  • Epigenetic profiling of AM subsets.

Main Results:

  • One month post-influenza, mice exhibited enhanced protection against Streptococcus pneumoniae.
  • This protection was mediated by a distinct population of monocyte-derived AMs producing increased interleukin-6.
  • Influenza-induced AMs possessed unique functional, transcriptional, and epigenetic profiles compared to resident AMs.

Conclusions:

  • Influenza infection alters lung immune cell composition, promoting a protective AM population.
  • Monocyte-derived AMs contribute to prolonged, but transient, antibacterial defense.
  • Transient respiratory infections continuously shape lung immunity through recruitment of new immune cells.